1 / 10

Global Gene Editing Market to reach $7.5bn by 2024

Get more details @ http://bit.ly/2fuA4tC <br>Major industry participants for the global gene editing market share include Agilent Technologies, Allele Biotech, AstraZeneca, Bio Rad, Cellectis, CRISPR Therapeutics, Editas Medicine, GE Healthcare Dharmacon, Lonza, Qiagen, Recombinetics, Sigma-Aldrich and Thermo Fisher Scientific.

jueekate
Download Presentation

Global Gene Editing Market to reach $7.5bn by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Gene Editing Market share to reach $7.5bn by 2024: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights from Gene Editing Market: • Gene Editing Market size is driven by rising number of biotechnology and pharmaceutical firms that will provide heavy revenue generating opportunities. • According to Global Market Insights, Inc. “Global gene editing market size worth USD 2.17 billion in 2015, is estimated to witness a CAGR of 14% over the period of 2016-2024”. • The rapid technological advancements in healthcare industry will also build a profitable roadmap for the gene-editing industry. • The pharmaceutical industry is also actively collaborating with the gene editing firms to implement the technology use in clinical development. In addition to this, the industry will gain wide acceptance on account of its benefits in the wellbeing of humans, animals, and plant ecosystems. • Gene editing industry finds a varied set of applications across areas such as oncology, muscular disorders, infectious disease, and hematology.

  3. Continued... • Hematology led the application landscape with a revenue of USD 807 million in 2015. Rising prevalence of infectious diseases such as HIV will promote the gene editing industry size in infectious disease applications, with a revenue estimation of USD 2.5 billion by 2024. • CRISPR/Cas9 is the most prominent technology implemented in the gene editing applications and has been the most buzzed topic among the researchers worldwide. • The major end-users participating in the gene editing market include CROs (Contract Research Organizations), Biotech & Pharma companies, and Research Institutes. • Considering the global trends, US gene editing industry led the global landscape, with a revenue of USD 518 million in 2015. • UK gene editing market is anticipated to surpass USD 744 million by 2024, driven by the growing geriatric population base and frequent occurrence of chronic ailments across Europe.

  4. Continued... • Asia Pacific will also exhibit substantial growth over the coming years. Improving healthcare infrastructure, technological developments in the medical space, rising geriatric population base, and favorable government norms will stimulate the APAC market growth. • The emerging economies will gain a major traction of the industry players to expand the regional base. • Key market participants include Agilent Technologies, AstraZeneca, Allele Biotech, Cellectis, Bio Rad, Editas Medicine, CRISPR Therapeutics, Lonza, GE Healthcare Dharmacon, Recombinetics, Inc., Qiagen, Thermo Fisher Scientific, and Sigma-Aldrich.

  5. U.S. Gene Editing Market Size, by Application, 2013- 2024 (USD Million)

  6. Table of Contents: Chapter 1. Methodology and Scope 1.1 Research Methodology 1.1.1 Initial data exploration 1.1.2 Statistical modeling and forecast 1.1.3 Industry insights and validation 1.1.4 Research scope and assumptions 1.2 List of Data Sources 1.2.1 Primary sources 1.2.2 Secondary sources Chapter 2. Executive Summary 2.1 Gene Editing industry 3600 synopsis, 2013 - 2024 2.1.1 Business trends 2.1.2 Application trends 2.1.3 Technology trends 2.1.4 End User trends 2.1.5 Regional trends

  7. Table of Contents: Chapter 3. Gene Editing Industry Insights 3.1 Industry segmentation 3.2 Industry size and future growth prospects, 2013 – 2024 3.3 Industry ecosystem analysis 3.3.1 Vendor matrix 3.4 Industry dynamics 3.4.1 Growth drivers 3.4.1.1 Increased funding for genetics research 3.4.1.2 Increased R&D expenditure and growth of biotechnology 3.4.1.3 Increasing demand for synthetic genes 3.4.1.4 Growing use of genetically modified technology 3.4.1.5 Technology advancements 3.4.2 Industry pitfalls & challenges 3.4.2.1 Stringent government regulations 3.4.2.2 Dearth of public awareness

  8. Table of Contents: 3.5 Regulatory trends 3.5.1 U.S. 3.5.2 Europe 3.5.3 China 3.6 Key growth opportunities 3.7 Company market share analysis, 2015 3.7.1 Strategy dashboard 3.8 Porter’s analysis 3.9 PESTEL analysis

  9. Browse Full Market Research Report On Gene Editing Market @ http://bit.ly/2firtKv Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/810https://www.gminsights.com/request-sample/detail/49

  10. Stay In Touch Website: www.gminsights.com Social Media:

More Related